HB 1350-FN (2024): relative to therapeutic cannabis possession limits.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1350-FN (2024): relative to therapeutic cannabis possession limits.” Granite Record, https://graniterecord.org/bill/2024/hb1350. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1350-FN (2024): relative to therapeutic cannabis possession limits. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/hb1350
- Chicago
- Granite Record. “HB 1350-FN (2024): relative to therapeutic cannabis possession limits.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/hb1350.
- BibTeX
@misc{bill-2024-hb1350, title = {HB 1350-FN (2024): relative to therapeutic cannabis possession limits.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/hb1350}, note = {Accessed 24 Oct. 2026} }
HB 1350-FN (2024)
relative to therapeutic cannabis possession limits.
- Status: Referred for interim study
- Term: 2023-2024
- House committee: Health, Human Services and Elderly Affairs
- Senate committee: Judiciary
- Subject: Public and Mental Health
The Story
It was introduced on January 3, 2024 and referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on January 18, 2024, with 59 people signed in online: 57 in support and 2 in opposition. The committee met in executive session on February 21, 2024 to vote on its recommendation. The committee voted unanimously, 19–0, to recommend that the House pass it, and the report was placed on the consent calendar. On March 7, 2024 the House voted to pass it on a voice vote. It crossed to the Senate on March 7, 2024 and was referred to the Senate Judiciary committee. The committee held a public hearing on April 25, 2024. On May 15, 2024 the Senate adopted “Special Order to 05/16/2024, Without Objection”. The committee voted 3–2 to recommend that the Senate study it after the session ends. On May 16, 2024 the Senate adopted “Refer to Interim Study” on a voice vote.
Sponsors
- Rep. Heath Howard (D - Straf 4) (prime sponsor)
- Rep. Wendy Thomas (D - Hills 12)
- Rep. Alissandra Murray (D - Hills 20)
- Rep. Jodi Newell (D - Ches 4)
- Rep. Christine Seibert (D - Hills 21)
Hearings and Sessions
- January 18, 2024, 1:00 PM: public hearing, House Health, Human Services and Elderly Affairs, LOB 210-211
- February 21, 2024, 11:00 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 203
- April 25, 2024, 1:15 PM: hearing, Senate Judiciary, SH 100
Votes
- March 7, 2024, House: Ought to Pass — voice vote, passed
- May 16, 2024, Senate: Refer to Interim Study — voice vote, passed
The Docket
- January 3, 2024: Introduced 01/03/2024 and referred to Health, Human Services and Elderly Affairs
- January 18, 2024: Public Hearing: 01/18/2024 01:00 pm LOB 210-211
- February 21, 2024: Executive Session: 02/21/2024 11:00 am LOB 203
- February 21, 2024: Committee Report: Ought to Pass 02/21/2024 (Vote 19-0; CC)
- March 7, 2024: Ought to Pass : MA VV 03/07/2024
- March 7, 2024: Introduced 03/07/2024 and Referred to Judiciary
- April 25, 2024: Hearing: 04/25/2024, Room 100, SH, 01:15 pm
- May 15, 2024: Special Order to 05/16/2024, Without Objection, MA; 05/15/2024
- May 16, 2024: Committee Report: Referred to Interim Study, 05/16/2024, Vote 3-2
- May 16, 2024: Refer to Interim Study, MA, VV; 05/16/2024
Laws It Would Change
Related Bills
- HB 190-FN (2025): relative to therapeutic cannabis possession limits.